Table 3.
NTTE (n = 26) | TTE (n = 37) | P valuea | |
---|---|---|---|
Median (range) | |||
Global health status | 83.3 (33.3–100) | 66.7 (8.3–100) | 0.004a |
Functional scales | |||
Physical | 100 (73.3–100) | 86.7 (20–100) | < 0.0001a |
Role | 100 (10–100) | 83.3 (0–100) | 0.007a |
Emotional | 91.7 (33.3–100) | 75 (0–100) | 0.113 |
Cognitive | 100 (50–100) | 66.7 (16.7–100) | 0.002a |
Social | 100 (33.3–100) | 83.3 (16.7–100) | 0.090 |
Symptom scales | |||
Fatigue | 22.2 (0–55.6) | 44.4 (0–100) | 0.003a |
Nausea and vomiting | 0 (0–33.3) | 0 (0–100) | 0.032a |
Pain | 0 (0–33.3) | 16.7 (0–100) | 0.025a |
Dyspnea | 33.3 (0–33.3) | 33.3 (0–100) | 0.655 |
Insomnia | 0 (0–66.7) | 33.3 (0–100) | 0.294 |
Appetite loss | 0 (0–66.7) | 33.3 (0–100) | 0.018a |
Constipation | 0 (0–100) | 0 (0–100) | 0.317 |
Diarrhea | 0 (0–100) | 0 (0–100) | 0.652 |
Financial difficulties | 0 (0–33.3) | 0 (0–100) | 0.336 |
NTTE nontransthoracic esophagectomy, TTE transthoracic esophagectomy
aWilcoxon rank-sum test